Compare DAR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAR | BIO |
|---|---|---|
| Founded | 1882 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.1B |
| IPO Year | 2002 | 1994 |
| Metric | DAR | BIO |
|---|---|---|
| Price | $55.49 | $372.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $81.83 | ★ $335.00 |
| AVG Volume (30 Days) | ★ 2.1M | 214.5K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $6,135,877,000.00 | $2,583,200,000.00 |
| Revenue This Year | $11.66 | N/A |
| Revenue Next Year | $2.80 | $2.13 |
| P/E Ratio | $16.90 | ★ N/A |
| Revenue Growth | ★ 7.36 | 0.65 |
| 52 Week Low | $31.62 | $236.73 |
| 52 Week High | $69.98 | $396.23 |
| Indicator | DAR | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.13 | 52.09 |
| Support Level | $51.10 | $364.41 |
| Resistance Level | $64.55 | $391.87 |
| Average True Range (ATR) | 2.19 | 11.19 |
| MACD | -0.41 | 2.28 |
| Stochastic Oscillator | 15.73 | 59.77 |
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.